US12208117B2ActiveUtilityA1
Glycerol and sodium pentaborate based formulation preventing postoperative adhesions
Est. expiryMay 30, 2039(~12.8 yrs left)· nominal 20-yr term from priority
A61L 2300/22A61L 2300/102A61L 31/16A61L 31/14A61L 2400/06A61K 33/22A61L 31/028
55
PatentIndex Score
0
Cited by
12
References
4
Claims
Abstract
A glycerol and sodium pentaborate based formulation developed for preventing postoperative adhesions occurring between manipulated tissues and organs is provided. An objective of the glycerol and sodium pentaborate based formulation is to provide a formulation comprising a mixture of glycerol, wherein the glycerol is one of the most abundant biomolecules in a human body, and sodium pentaborate, wherein the sodium pentaborate is known to have positive effects on a wound healing, with a purpose of preventing the postoperative adhesions.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A glycerol and sodium pentaborate based formulation consisting of a mixture of glycerol and sodium pentaborate in a physiological saline solution, wherein the glycerol and sodium pentaborate based formulation blocks fibrosis and collagen production, preventing adhesion between tissues and organs manipulated at a surgical site as a result of surgical intervention.
2. The glycerol and sodium pentaborate based formulation according to claim 1 , wherein the glycerol has a concentration varying between 1% and 10%.
3. The glycerol and sodium pentaborate based formulation according to claim 1 , wherein the sodium pentaborate has a concentration varying between 1% and 10%.
4. The glycerol and sodium pentaborate based formulation according to claim 1 , wherein the glycerol and sodium pentaborate based formulation is in the form of a spray.Join the waitlist — get patent alerts
Track US12208117B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.